Wystepowanie Corynebacterium amycolatum w materiale klinicznym

• Autorzy: Zalas P. , Mikucka A. , Gospodarek E.

Warianty tytułu

EN

Occurrence of Corynebacterium amycolatum strains in clinical specimens

• Języki publikacji: PL

Abstrakty

PL

Oceniono częstość występowania szczepów Corynebacterium amycolatum w próbkach różnego materiału klinicznego. Badaniem objęto 70 szczepów. Największy udział miały szczepy izolowane z wymazów z ran (61,5%), z moczu (14,3%) i wymazów z drenu (7,1%). Pochodziły one głównie (37,2%) od pacjentów leczonych w oddziałach chirurgicznych (chirurgia ogólna, chirurgia naczyń, kardiochirurgia).

EN

C. amycolatum is poorly recognized and rarely described in the world literature. So, better recognizing and understanding biology of these bacteria may help effectivly prevent infections caused by them. The subject within the study were 70 of C. amycolatum strains which were isolated from the clinical specimens of patients hospitalized at the State Clinical Hospital in Bydgoszcz. After initial identification of examinated strains based on Gram staining results, colonial morphology, biochemical and enzymatic features included in API Coryne and API ZYM tests (bioMérieux), growth at 20°C, Tween 80 requirement, DNA and tyrosine hydrolysis, occurrence in clinical specimens and origin of C. amycolatum strains were analized. The investigated strains were the most frequently isolated from wound swabs (61.5%), urine (14.3%), drain swabs (7.1%) and mainly (37.2%) came from patients treated at the departments of surgery.

Słowa kluczowe

PL

wystepowanie; szczepy bakteryjne; material kliniczny; pacjenci; Corynebacterium amycolatum; wymazy z ran; chirurgia; mocz; bakterie; dreny

• Wydawca: -
• Czasopismo: Medycyna Doświadczalna i Mikrobiologia
• Rocznik: 2004
• Tom: 56
• Numer: 2
• Opis fizyczny: s.139-145,rys.,tab.,bibliogr.

Twórcy

autor

Zalas P.

• Akademia Medyczna, Bydgoszcz

autor

Mikucka A.

autor

Gospodarek E.

Bibliografia

• 1. Berner R, Pelz K, Wilhelm C i inni. Fatal sepsis caused by Corynebacterium amycolatum in a premature infant. J Clin Microbiol 1997; 35: 1011-2.
• 2. Clarke R, Qamruddin A, Taylor M, Panigrahi H. Septic arthritis caused by Corynebacterium amycolatum following vascular graft sepsis. J Infect 1999; 38: 126-7.
• 3. Collins MD, Burton RA, Jones D. Corynebacterium amycolatum sp. nov. a new mycolic acid-less Corynebacterium species from human skin. FEMS Microbiol Lett 1988; 49: 349-52.
• 4. Daniels C, Schoors D, van Camp G. Native valve endocarditis with aorta-to-left atrial fistula due to Corynebacterium amycolatum. Eur J Echocardiogr 2003; 4: 68-70.
• 5. de Miguel J, Rodriguez E, Martin AM. Corynebacterium amycolatum: sepsis in hematologic patients. Enferm Infect Microbiol Clin 1999; 17: 340-1.
• 6. Esteban J, Nieto E, Calvo R i inni. Microbiological characterization and clinical significance of Corynebacterium amycolatum strains. Eur J Clin Microbiol Infect Dis 1999; 18: 518-21.
• 7. Funke G, Lawson PA, Bernard KA, Collins MD. Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum. J Clin Microbiol 1996; 34: 1124-8.
• 8. Funke G, Pźnter V, von Graevenitz A. Animicrobial susceptibility patterns of some recently established coryneform bacteria. Antimicrob Ag Chemother 1996; 40: 2874-8.
• 9. Funke G, von Graevenitz A, Clarridge III JE, Bernard KA. Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 1997; 10: 125-59.
• 10. Knox KL, Holmes AH. Nosocomial endocarditis caused by Corynebacterium amycolatum and other nondiphtheriae corynebacteria. Emerg Infect Dis 2002; 8: 97-9.
• 11. Lagrou K, Verhaegen J, Janssens M i inni. Prospective study of catalase-positive coryneform organisms in clinical relevance and antibiotic susceptibility. Diagn Microbiol Infect Dis 1998; 30: 7-15.
• 12. Mikucka A, Gospodarek E, Białek M. Opportunistic infections with coryneform. Med Sci Monit 1997; 3: 154-7.
• 13. Mikucka A. Oportunistyczne gatunki coryneform w zakażeniach szpitalnych. Akademia Medyczna im. L. Rydygiera, Bydgoszcz 2001. Praca doktorska.
• 14. Oteo J, Aracil B, Ignacio-Alos J, Luis-Gomez-Garces J. Significant bacteriemias by Corynebacterium amycolatum: an emergent pathogen. Enferm Infect Microbiol Clin 2001; 19: 103-6.
• 15. Paviour S, Musaad S, Roberts S i inni. Corynebacterium species isolated from patients with mastitis. Clin Infect Dis 2002; 35: 1434-40.
• 16. Smith RF. Characterization of human cutaneous lipophilic diphtheroids. J Gen Microbiol 1969; 55: 433-13.
• 17. Soriano F, Zapardiel J, Nieto E. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob Ag Chemother 1995; 39: 208-14
• 18. Vaneechoutte M, De-Bleser D, Claeys G i inni. Cardioverter-lead electrode infection due to Corynebacterium amycolatum. Clin. Infect. Dis. 1998; 27: 1553-4.
• 19. von Graevenitz A, Frommelt L, Pźnter—Streit V, Funke G. Diversity of coryneforms found in infections following prosthetic joint insertion and open fractures. Infection 1998; 26: 36-8.
• 20. Wauters G, van Bosterhaut B, Janssens M, Verhaegen J. Identification of Corynebacterium amycolatum and other nonlipophilic fermentative corynebacteria of human origin. J Clin Microbiol 1998; 36: 1430-2.
• 21. Zinkernagel AS, von Graevenitz A, MD, Funke Guido, MD. Heterogeneity within Corynebacterium minutissimum strains is explained by misidentified Corynebacterium amycolatum strains. Am J Clin Pathol 1996; 106: 378-83.